30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Timber Pharmaceuticals Inc (TMBR)

Track

Stock chart
Ticker: TMBR Exchange: ASE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Koconis John
CEO & President
1 purchase — total 7,686 USD
Buy 15 Dec 2021
Value US$4,480,286.76 | Price 321.45 | Shares 89,892
Buy 23 Nov 2021
Value US$1,343,160.82 | Price 366.81 | Shares 57,566
Buy 23 Nov 2021
Value US$4,700.00 | Price 0.47 | Shares 10,000
Sale 20 Aug 2021
Value US$45,395.00 | Price 0.91 | Shares 50,000
Sale 19 Aug 2021
Value US$47,700.00 | Price 0.95 | Shares 50,000
Sale 18 Aug 2021
Value US$75,075.00 | Price 1.00 | Shares 75,000
Sale 10 Jun 2021
Value US$233,925.70 | Price 1.26 | Shares 185,229
Sale 9 Jun 2021
Value US$122,907.15 | Price 1.27 | Shares 96,481
Sale 8 Jun 2021
Value US$393,382.75 | Price 1.29 | Shares 305,540
Sale 2 Jun 2021
Value US$12,447.54 | Price 1.26 | Shares 9,879
Sale 1 Jun 2021
Value US$10,951.94 | Price 1.26 | Shares 8,670
Sale 28 May 2021
Value US$60,619.95 | Price 1.27 | Shares 47,736
Buy 3 Mar 2021
Value US$4,313.96 | Price 2.17 | Shares 1,988
Sale 16 Sep 2020
Value US$103,694.68 | Price 1.03 | Shares 100,694
Sale 15 Sep 2020
Value US$89,549.92 | Price 1.03 | Shares 87,060
Sale 14 Sep 2020
Value US$468.65 | Price 1.03 | Shares 455
Sale 11 Sep 2020
Value US$7,709.73 | Price 1.03 | Shares 7,483
Sale 10 Sep 2020
Value US$34,379.31 | Price 1.04 | Shares 32,943
Sale 10 Feb 2020
Value US$550.08 | Price 0.01 | Shares 55,008
Sale 10 Feb 2020
Value US$550.08 | Price 0.01 | Shares 55,008
Sale 25 Jun 2019
Value US$334,427.40 | Price 1.02 | Shares 327,870
Sale 23 Jan 2019
Value US$12,746.14 | Price 0.11 | Shares 115,874
Sale 22 Oct 2018
Value US$45,192.78 | Price 0.18 | Shares 251,071
Sale 22 Oct 2018
Value US$39,737.88 | Price 0.18 | Shares 220,766
Sale 19 Oct 2018
Value US$38,536.38 | Price 0.18 | Shares 214,091
Sale 18 Oct 2018
Value US$83,428.81 | Price 0.19 | Shares 439,099
Sale 12 Oct 2018
Value US$56,525.00 | Price 0.19 | Shares 297,500
Sale 11 Oct 2018
Value US$19,000.00 | Price 0.19 | Shares 100,000
Sale 10 Oct 2018
Value US$19,475.00 | Price 0.19 | Shares 102,500
Buy 19 Sep 2018
Value US$20,250.00 | Price 0.20 | Shares 100,000
Sale 7 Mar 2018
Value US$720,000.00 | Price 0.36 | Shares 2,000,000
Buy 24 Nov 2017
Value US$49,500.00 | Price 0.15 | Shares 330,000
Sale 9 Nov 2017
Value US$59,278.80 | Price 0.20 | Shares 296,394
Buy 1 Aug 2017
Value US$84,300.00 | Price 0.34 | Shares 250,000
Buy 28 Apr 2017
Value US$1,000,000.56 | Price 0.78 | Shares 1,282,052
Buy 22 Nov 2016
Value US$0.00 | Price 0.00 | Shares 4,375,000
Buy 15 Aug 2016
Value US$314,999.75 | Price 0.65 | Shares 484,615
Buy 29 Mar 2016
Value US$648,000.00 | Price 1.20 | Shares 540,000
Buy 14 Jan 2016
Value US$8,415.00 | Price 1.53 | Shares 5,500
Buy 13 Jan 2016
Value US$9,880.00 | Price 1.52 | Shares 6,500
Buy 12 Jan 2016
Value US$4,890.00 | Price 1.63 | Shares 3,000
Buy 11 Jan 2016
Value US$4,290.00 | Price 1.43 | Shares 3,000
Buy 7 Jan 2016
Value US$7,350.00 | Price 1.47 | Shares 5,000
Buy 15 Oct 2015
Value US$3,690.00 | Price 1.23 | Shares 3,000
Buy 14 Oct 2015
Value US$2,500.00 | Price 1.25 | Shares 2,000
Buy 9 Oct 2015
Value US$2,380.00 | Price 1.19 | Shares 2,000
Buy 9 Oct 2015
Value US$1,260.00 | Price 1.26 | Shares 1,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2021-12-16 2021-12-15 B Purchase
Koconis John

CEO & President

Executive Director
89,892 +2.8%
321.45
US$4,480,287 		89,892 +2.8% 321.45 US$4,480,287
2021-11-24 2021-11-23 B Purchase
Sitar Edward J
Non-Executive Director
57,566 -3.7%
366.81
US$1,343,161 		57,566 -3.7% 366.81 US$1,343,161
2021-11-24 2021-11-23 B Purchase
Mendelsohn Alan

Chief Medical Officer

Officer
4,559 +19.2%
488.35
US$3,526,897 		4,559 +19.2% 488.35 US$3,526,897
2021-08-20 2021-08-20 S Sale
0.5
TardiMed Sciences LLC
Large shareholder
50,000 -1.1%
0.91
US$45,395 		50,000 -1.1% 0.91 US$45,395
2021-08-20 2021-08-19 S Sale
0.5
TardiMed Sciences LLC
Large shareholder
50,000 -1.1%
0.95
US$47,700 		50,000 -1.1% 0.95 US$47,700
2021-08-20 2021-08-18 S Sale
0.5
TardiMed Sciences LLC
Large shareholder
75,000 -1.6%
1.00
US$75,075 		75,000 -1.6% 1.00 US$75,075
2021-06-10 2021-06-10 S Sale
0.5
TardiMed Sciences LLC
Large shareholder
185,229 -3.7%
1.26
US$233,926 		185,229 -3.7% 1.26 US$233,926
2021-06-10 2021-06-09 S Sale
0.5
TardiMed Sciences LLC
Large shareholder
96,481 -1.9%
1.27
US$122,907 		96,481 -1.9% 1.27 US$122,907
2021-06-10 2021-06-08 S Sale
0.5
TardiMed Sciences LLC
Large shareholder
305,540 -5.7%
1.29
US$393,383 		305,540 -5.7% 1.29 US$393,383
2021-06-02 2021-06-02 S Sale
0.5
TardiMed Sciences LLC
Large shareholder
9,879 -0.2%
1.26
US$12,448 		9,879 -0.2% 1.26 US$12,448
2021-06-02 2021-06-01 S Sale
0.5
TardiMed Sciences LLC
Large shareholder
8,670 -0.2%
1.26
US$10,952 		8,670 -0.2% 1.26 US$10,952
2021-06-02 2021-05-28 S Sale
0.5
TardiMed Sciences LLC
Large shareholder
47,736 -0.9%
1.27
US$60,620 		47,736 -0.9% 1.27 US$60,620
2021-05-13 2021-03-03 B Purchase
Mendelsohn Alan

Chief Medical Officer

Officer
1,988 +inf%
2.17
US$4,314 		1,988 +inf% 2.17 US$4,314
2020-09-16 2020-09-16 S Sale
0.5
TardiMed Sciences LLC
Large shareholder
100,694 -1.8%
1.03
US$103,695 		100,694 -1.8% 1.03 US$103,695
2020-09-16 2020-09-15 S Sale
0.5
TardiMed Sciences LLC
Large shareholder
87,060 -1.5%
1.03
US$89,550 		87,060 -1.5% 1.03 US$89,550
2020-09-16 2020-09-14 S Sale
0.5
TardiMed Sciences LLC
Large shareholder
455 -0.0%
1.03
US$469 		455 -0.0% 1.03 US$469
2020-09-14 2020-09-11 S Sale
0.5
TardiMed Sciences LLC
Large shareholder
7,483 -0.1%
1.03
US$7,710 		7,483 -0.1% 1.03 US$7,710
2020-09-14 2020-09-10 S Sale
0.5
TardiMed Sciences LLC
Large shareholder
32,943 -0.6%
1.04
US$34,379 		32,943 -0.6% 1.04 US$34,379
2020-02-12 2020-02-10 S Sale
Timber Pharmaceuticals LLC
Large shareholder
55,008 -2.4%
0.01
US$550 		55,008 -2.4% 0.01 US$550
2020-02-12 2020-02-10 S Sale
0.5
TardiMed Sciences LLC
Large shareholder
55,008 -2.4%
0.01
US$550 		55,008 -2.4% 0.01 US$550
2019-06-27 2019-06-25 S Sale
2.4
Vivo Capital VIII, LLC
Large shareholder
327,870 -50.8%
1.02
US$334,427 		327,870 -50.8% 1.02 US$334,427
2019-01-25 2019-01-23 S Sale
Krammer Anja B
Non-Executive Director
115,874 -5.8%
0.11
US$12,746 		115,874 -5.8% 0.11 US$12,746
2018-10-22 2018-10-22 S Sale Morlock Stephen Non-Executive Director
251,071 -100.0%
0.18
US$45,193 		251,071 -100.0% 0.18 US$45,193
2018-10-22 2018-10-22 S Sale Morlock Stephen Non-Executive Director
220,766 -100.0%
0.18
US$39,738 		220,766 -100.0% 0.18 US$39,738
2018-10-22 2018-10-19 S Sale Morlock Stephen Non-Executive Director
214,091 -49.2%
0.18
US$38,536 		214,091 -49.2% 0.18 US$38,536
2018-10-22 2018-10-18 S Sale Morlock Stephen Non-Executive Director
439,099 -50.2%
0.19
US$83,429 		439,099 -50.2% 0.19 US$83,429
2018-10-12 2018-10-12 S Sale Krammer Anja B Non-Executive Director
297,500 -12.9%
0.19
US$56,525 		297,500 -12.9% 0.19 US$56,525
2018-10-12 2018-10-11 S Sale Krammer Anja B Non-Executive Director
100,000 -4.2%
0.19
US$19,000 		100,000 -4.2% 0.19 US$19,000
2018-10-12 2018-10-10 S Sale Krammer Anja B Non-Executive Director
102,500 -4.1%
0.19
US$19,475 		102,500 -4.1% 0.19 US$19,475
2018-09-20 2018-09-19 B Purchase Tierney David S

CEO

Executive Director
100,000 +1.4%
0.20
US$20,250 		100,000 +1.4% 0.20 US$20,250
2018-03-09 2018-03-07 S Sale Vivo Capital VIII, LLC Large shareholder
2,000,000 -11.0%
0.36
US$720,000 		2,000,000 -11.0% 0.36 US$720,000
2017-11-27 2017-11-24 B Purchase Morlock Stephen
330,000 +60.7%
0.15
US$49,500 		330,000 +60.7% 0.15 US$49,500
2017-11-13 2017-11-09 S Sale Vivo Capital VIII, LLC Large shareholder
296,394 -2.1%
0.20
US$59,279 		296,394 -2.1% 0.20 US$59,279
2017-08-03 2017-08-01 B Purchase FRANKLIN RESOURCES INC Large shareholder
250,000 +2.6%
0.34
US$84,300 		250,000 +2.6% 0.34 US$84,300
2017-05-01 2017-04-28 B Purchase Vivo Capital Fund VIII, L.P. Large shareholder
1,282,052 +10.0%
0.78
US$1,000,001 		1,282,052 +10.0% 0.78 US$1,000,001
2016-11-30 2016-11-22 B Purchase FRANKLIN RESOURCES INC Large shareholder
4,375,000
0.00
US$0 		4,375,000 0.00 US$0
2016-08-16 2016-08-15 B Purchase FRANKLIN RESOURCES INC Large shareholder
484,615 +10.4%
0.65
US$315,000 		484,615 +10.4% 0.65 US$315,000
2016-03-31 2016-03-29 B Purchase FRANKLIN RESOURCES INC Large shareholder
540,000 +13.2%
1.20
US$648,000 		540,000 +13.2% 1.20 US$648,000
2016-01-15 2016-01-14 B Purchase Morlock Stephen Non-Executive Director
5,500 +2.2%
1.53
US$8,415 		5,500 +2.2% 1.53 US$8,415
2016-01-15 2016-01-13 B Purchase Morlock Stephen Non-Executive Director
6,500 +2.7%
1.52
US$9,880 		6,500 +2.7% 1.52 US$9,880
2016-01-12 2016-01-12 B Purchase Morlock Stephen Non-Executive Director
3,000 +1.3%
1.63
US$4,890 		3,000 +1.3% 1.63 US$4,890
2016-01-12 2016-01-11 B Purchase Morlock Stephen Non-Executive Director
3,000 +1.3%
1.43
US$4,290 		3,000 +1.3% 1.43 US$4,290
2016-01-11 2016-01-07 B Purchase Morlock Stephen Non-Executive Director
5,000 +2.2%
1.47
US$7,350 		5,000 +2.2% 1.47 US$7,350
2015-10-15 2015-10-15 B Purchase Morlock Stephen Non-Executive Director
3,000 +1.3%
1.23
US$3,690 		3,000 +1.3% 1.23 US$3,690
2015-10-15 2015-10-14 B Purchase Morlock Stephen Non-Executive Director
2,000 +0.9%
1.25
US$2,500 		2,000 +0.9% 1.25 US$2,500
2015-10-13 2015-10-09 B Purchase Morlock Stephen Non-Executive Director
2,000 +0.9%
1.19
US$2,380 		2,000 +0.9% 1.19 US$2,380
2015-10-13 2015-10-09 B Purchase Morlock Stephen Non-Executive Director
1,000 +0.5%
1.26
US$1,260 		1,000 +0.5% 1.26 US$1,260
Explore more

More insider trading research around Timber Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America